Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy

R. I. Lalisang*, Frans L. G. Erdkamp, C. J. Rodenburg, C. T. A. M. Knibbeler-van Rossum, J.W.R. Nortier, A. van Bochove, P. H. Th. J. Slee, E.E. Voest, J.A. Wils, J. Wals, Olaf J. L. Loosveld, A. E. M. Smals, G.H. Blijham, V. C. G. Tjan-Heijnen, H. C. Schouten

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Web of Science)
Original languageEnglish
Pages (from-to)437-445
JournalBreast Cancer Research and Treatment
Volume128
Issue number2
DOIs
Publication statusPublished - Jul 2011

Keywords

  • Combination chemotherapy
  • Breast neoplasm's
  • Dose-dense
  • Dose-intensive
  • Epirubicin
  • Paclitaxel

Cite this